[go: up one dir, main page]

YU171590A - Kondenzovani diazepinoni i postupak za njihovo dobijanje - Google Patents

Kondenzovani diazepinoni i postupak za njihovo dobijanje

Info

Publication number
YU171590A
YU171590A YU171590A YU171590A YU171590A YU 171590 A YU171590 A YU 171590A YU 171590 A YU171590 A YU 171590A YU 171590 A YU171590 A YU 171590A YU 171590 A YU171590 A YU 171590A
Authority
YU
Yugoslavia
Prior art keywords
treatment
lower alkyl
halogen
spasms
methyl
Prior art date
Application number
YU171590A
Other languages
English (en)
Other versions
YU47372B (sh
Inventor
W. Engel
W. Eberlein
G. Trummlitz
G. Mihm
H. Doods
N. Mayer
A. Jonge
Original Assignee
Dr. Karl Thomae Gesellschaft Mit Beschraenkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gesellschaft Mit Beschraenkter Haftung filed Critical Dr. Karl Thomae Gesellschaft Mit Beschraenkter Haftung
Publication of YU171590A publication Critical patent/YU171590A/sh
Publication of YU47372B publication Critical patent/YU47372B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Kondenzirani diazepinoni s splošno formulo I kjer pomeni B enega od dvovalentnih ostankov X skupino=CH-ali atom dušika, R nižji alkilni ostanek, ki je v danem primeru lahko substituiran z v danem primeru halogenom, metilom ali metoksi, fenilom, ki nosi metoksi, R4 in R5 predstavljata vodik, halogen ali nižji alkil, R6 je vodik, klor ali metil, R7 in R8 sta nižji alkil, R8 pomeni dodatno še halogen in so m,n,o, inp števila 1 ali 2, pri čemer mora biti je vsota iz m+n+o+p enaka ali manjša kot 6, so primerni za terapijo holinergično pogojenih krčev in prebavnih motenj v želodčno- črevesnem traktu v področju izločenja žolčnika, za simptomatično terapijo cistitisa in krčev pri urelitiazi, za terapijo relativne inkontinence, za simptomatično terapijo bronhialne astme in bronhitisa, kot tudi za terapijo ishemičnih srčnih obolenj. Spojine se odlikujejo po visoki selektivnosti.
YU171590A 1989-09-11 1990-09-10 Kondenzovani diazepinoni i postupak za njihovo dobijanje YU47372B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3930262A DE3930262A1 (de) 1989-09-11 1989-09-11 Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
YU171590A true YU171590A (sh) 1993-05-28
YU47372B YU47372B (sh) 1995-01-31

Family

ID=6389152

Family Applications (1)

Application Number Title Priority Date Filing Date
YU171590A YU47372B (sh) 1989-09-11 1990-09-10 Kondenzovani diazepinoni i postupak za njihovo dobijanje

Country Status (17)

Country Link
EP (1) EP0417631A3 (sh)
JP (1) JPH03209382A (sh)
KR (1) KR910006286A (sh)
AU (1) AU626452B2 (sh)
CA (1) CA2025005A1 (sh)
DD (1) DD299308A5 (sh)
DE (1) DE3930262A1 (sh)
FI (1) FI904469A0 (sh)
HU (1) HU206882B (sh)
IL (1) IL95622A (sh)
NO (1) NO903941L (sh)
NZ (1) NZ235270A (sh)
PL (1) PL165197B1 (sh)
PT (1) PT95259A (sh)
RU (1) RU2017740C1 (sh)
YU (1) YU47372B (sh)
ZA (1) ZA907199B (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3930266A1 (de) * 1989-09-11 1991-03-14 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2355157T3 (es) 2002-07-05 2011-03-23 Targacept, Inc. Compuestos diazaspirocíclico n-arilo y métodos de preparación y uso de las mismas.
SE0202133D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
US8809552B2 (en) * 2011-11-01 2014-08-19 Hoffmann-La Roche Inc. Azetidine compounds, compositions and methods of use
MY180688A (en) * 2012-06-13 2020-12-07 Hoffmann La Roche New diazaspirocycloalkane and azaspirocycloalkane
BR112015004111A2 (pt) 2012-09-25 2017-07-04 Hoffmann La Roche novos derivados bicíclicos
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
WO2015078803A1 (en) 2013-11-26 2015-06-04 F. Hoffmann-La Roche Ag NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YL
AU2015238537B2 (en) 2014-03-26 2019-08-01 F. Hoffmann-La Roche Ag Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
AU2015238541B2 (en) 2014-03-26 2019-09-19 F. Hoffmann-La Roche Ag Condensed [1,4]diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
CA2992889A1 (en) 2015-09-04 2017-03-09 F. Hoffmann-La Roche Ag Phenoxymethyl derivatives
BR112018006034A2 (pt) 2015-09-24 2018-10-09 Hoffmann La Roche compostos bicíclicos como inibidores de atx
BR112018006024A2 (pt) 2015-09-24 2020-05-12 F. Hoffmann-La Roche Ag Compostos bicíclicos como inibidores de atx
CA2991612A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag New bicyclic compounds as dual atx/ca inhibitors
CR20180143A (es) 2015-09-24 2018-05-03 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de atx/ca
JP7090099B2 (ja) 2017-03-16 2022-06-23 エフ．ホフマン－ラ ロシュ アーゲー Ａｔｘインヒビターとしての新規二環式化合物
CN110392679B (zh) 2017-03-16 2023-04-07 豪夫迈·罗氏有限公司 可用作双重atx/ca抑制剂的杂环化合物
ES2951874T3 (es) * 2017-09-05 2023-10-25 Neumora Therapeutics Inc Antagonistas del receptor de vasopresina y productos y métodos relacionados con los mismos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210648A (en) * 1977-05-31 1980-07-01 Boehringer Ingelheim Gmbh II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof
DE3204153A1 (de) * 1982-02-06 1983-08-11 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3204403A1 (de) * 1982-02-09 1983-08-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3930266A1 (de) * 1989-09-11 1991-03-14 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
FI904469A0 (fi) 1990-09-11
EP0417631A2 (de) 1991-03-20
JPH03209382A (ja) 1991-09-12
RU2017740C1 (ru) 1994-08-15
AU626452B2 (en) 1992-07-30
HU905852D0 (en) 1991-03-28
KR910006286A (ko) 1991-04-29
NO903941L (no) 1991-03-12
AU6235290A (en) 1991-03-14
DD299308A5 (de) 1992-04-09
EP0417631A3 (en) 1991-12-11
HUT55393A (en) 1991-05-28
YU47372B (sh) 1995-01-31
IL95622A (en) 1994-04-12
PL286835A1 (en) 1991-08-26
ZA907199B (en) 1992-05-27
IL95622A0 (en) 1991-06-30
NO903941D0 (no) 1990-09-10
PT95259A (pt) 1991-05-22
DE3930262A1 (de) 1991-03-21
HU206882B (en) 1993-01-28
CA2025005A1 (en) 1991-03-12
PL165197B1 (pl) 1994-11-30
NZ235270A (en) 1991-11-26

Similar Documents

Publication Publication Date Title
YU171590A (sh) Kondenzovani diazepinoni i postupak za njihovo dobijanje
SE8004002L (sv) Terapeutiskt anvendbara tetralinderivat
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
ATE358122T1 (de) Inhibitoren der tnf-alpha bildung zur behandlung von autoimmunerkrankungen
DE69116127D1 (de) Piperazinderivate
NZ338016A (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
SE8307133D0 (sv) Carboxamido-derivatives of 5h-1,3,4-thiadiazolo(3,2-a)pyrimidines and process for their preparation
IT1205958B (it) Derivati di acido chinolincarbossilico e procedimento per la loro preparazione
DK0479546T3 (da) Piperazinderivater
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
KR970003440A (ko) 삼환 5,6-디하이드로-9H-피라졸로[3,4-c]-1,2,4-트리아졸로[4,3-α]피리딘
ATE24503T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
GR3022821T3 (en) Modified oligodeoxyribonucleotides, their preparation and their therapeutic use.
ES2056835T3 (es) Derivados de pirido(2,3-d)pirimidina.
ATE116650T1 (de) Sulfonylamin substituierte bizyklische hydroxansäurederivate.
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
MY103502A (en) Novel compounds
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation
ATE374366T1 (de) Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen
GB2334032A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
ATE229953T1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
PT1140925E (pt) 3,4-di-hidro-2h-benzo¬1,4|oxazinil-metil-¬3-(1h-indol-3il)-alquil|-aminas
ATE74357T1 (de) 5-hetero- oder -aryl-substituierte imidazo(2,1a>isochinoline.